Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. - Wikidata - wikimedia - TriplyDB

Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.

Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.

http://www.wikidata.org/entity/Q33401403

about

Is solvent/detergent plasma better than standard fresh-frozen plasma? A systematic review and an expert consensus document Clinical Features of Neuropsychiatric Syndromes in Systemic Lupus Erythematosus and Other Connective Tissue Diseases Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Prognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012.Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products. British Committee for Standards in Haematology.Pernicious Anemia Associated Cobalamin Deficiency and Thrombotic Microangiopathy: Case Report and Review of the Literature Diagnosis and management of maternal thrombocytopenia in pregnancy.A phenotype-genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom.Thrombotic thrombocytopenic purpura-what is new?Unresponsive thrombotic thrombocytopenic purpura in critically ill adults.ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: implications for selection of plasma preparations for thrombotic thrombocytopenic purpura treatment.A postoperative thrombotic thrombocytopenic purpura in a cardiac surgery patient: a case report Diagnosis and management of thrombotic microangiopathy: the role of registries.Hemolysis and schistocytosis in the emergency department: consider pseudothrombotic microangiopathy related to vitamin B12 deficiency.[Hemato-oncological diseases].Thrombotic thrombocytopenic purpura: three peripartum cases and diagnostic challenges.Characterization of the complications associated with plasma exchange for thrombotic thrombocytopaenic purpura and related thrombotic microangiopathic anaemias: a single institution experience.Pulmonary involvement in patients with thrombotic thrombocytopenic purpura.Complement and cytokine response in acute Thrombotic Thrombocytopenic Purpura.Postoperative thrombotic thrombocytopenic purpura.How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura Thrombotic microangiopathy in a patient with adult-onset Still's disease.Acquired thrombotic thrombocytopenic purpura due to antibody-mediated ADAMTS13 deficiency precipitated by a localized Castleman's disease: a case report.Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation.How we approach an acquired thrombotic thrombocytopenic purpura patient.Effect of plasma exchange and immunosuppressive medications on antibody titers and outcome in anti-complement factor H antibody-associated hemolytic uremic syndrome.Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report Outcomes of platelet transfusion in patients with thrombotic thrombocytopenic purpura: a retrospective case series study.Thrombotic Thrombocytopenic Purpura-Haemolytic Uremic Syndrome and pregnancy.Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpura.Absolute immature platelet count dynamics in diagnosing and monitoring the clinical course of thrombotic thrombocytopenic purpura.ADAMTS-13 in the Diagnosis and Management of Thrombotic Microangiopathies.Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center.Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case-control study.Hospital-acquired thrombocytopenia.Nonsteroidal Anti-inflammatory Drug Induced Thrombotic Thrombocytopenic Purpura Catastrophic APS in the context of other thrombotic microangiopathies.Platelet transfusion and catheter insertion for plasma exchange in patients with thrombotic thrombocytopenic purpura and a low platelet count.

P2860

Q26748355-01CFB602-B355-486E-AA71-FCB9359EBFBA Q26773164-977F1531-AB80-4130-84F4-BEE7DB84A0EE Q26773305-3F646C24-2A38-422D-A282-31D7DD67E5E4 Q30276550-A362D321-A89A-415C-BF16-CB2E273728CE Q31077457-AF5BD9B3-B56A-4CF2-9035-03D1231B418C Q33165774-DCCCF2D9-B06B-455F-A5E7-A145B76121EB Q33168354-A344552A-516F-4A26-A3C6-73453164007C Q33401045-6C78E7ED-2AA1-42FE-930D-A1718FCBA642 Q33402274-E099A379-84EC-48D3-A3E1-603AF0374941 Q33405965-814D62DE-89A8-4040-BBF6-47510551B325 Q33406785-EF183943-118E-4E93-B416-7AC28E2214AC Q33406892-5EE18D9B-DF79-4F67-9ED9-5F021E06F036 Q33408411-B659AC36-E053-475E-88F2-6EDA9CBFD45E Q33408670-0CA32A69-B8BE-4530-85F4-6D5B1F06AB1B Q33409028-F85D07B5-BA9F-49BD-B4F9-EAF943722F7B Q33410075-A5939212-CE72-4530-84A2-4EA71630D302 Q33410727-5446A66F-523B-4120-A0A3-BC7F5EA9261B Q33410864-5F1EFCD6-6825-4957-8731-89B87B4A0750 Q33411161-7179032F-397E-429E-B280-DA59FEB1C16F Q33412347-B88F9210-475B-40DD-B786-1C2469789052 Q33412350-1B21067F-1138-4E84-999F-ED84BAA18658 Q33412445-9D8B72D1-F04B-4825-8BB1-741EBD3DDAF7 Q33412520-F2C9FA26-E91F-4DDC-BEF0-BB909114EB3E Q33415416-D87C0414-A025-45CB-88BD-C01A0827C7AD Q33415463-5C139B25-4497-480D-8C38-0A95C236325A Q33415693-B8635A8F-7D2B-44A6-94AB-3DD0AD067E44 Q33416780-3FBD6D9F-248C-4C8D-825D-EE4AF05DCEB6 Q33417644-286B01FF-CD4F-4949-B2C4-49B2552A16C0 Q33417655-2ECC176D-984C-404D-9629-6D6DCCC27D2D Q33418013-0273B5B3-D5D7-4056-973F-190EF5F326ED Q33418161-52C8812B-E803-4597-A1B1-F32786B0D628 Q33418352-B76E29C2-2F77-4696-A373-AEDA7B643250 Q33418539-4DDDBB09-419A-4ACF-B45A-78BBB2E734D2 Q33418645-4771D4E3-0D48-49FA-8902-CE115B77C6C3 Q33418732-76337D38-7F92-4D8A-BFAA-60A6A347C2CB Q33418909-C9EFC163-349D-4DCF-97E5-36E6719976B7 Q33419312-AC5C418A-5EAB-4FF5-BC7F-9F712E7424EA Q33419365-26AAC6F5-7143-4D32-8A88-C1E6465C23A7 Q33419886-9498C008-A435-4BD2-816F-B7CAA56A6337 Q33420604-1C46C95C-F4D2-4579-B2A5-B08E6C7C5272

P2860

Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.

http://www.wikidata.org/entity/Q33401403

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Guidelines on the diagnosis an ...... thrombotic microangiopathies.

@ast

Guidelines on the diagnosis an ...... thrombotic microangiopathies.

@en

type

label

Guidelines on the diagnosis an ...... thrombotic microangiopathies.

@ast

Guidelines on the diagnosis an ...... thrombotic microangiopathies.

@en

prefLabel

Guidelines on the diagnosis an ...... thrombotic microangiopathies.

@ast

Guidelines on the diagnosis an ...... thrombotic microangiopathies.

@en

P1433

Q33401403-3416A4DA-B643-4C51-B1FE-96689582C3F3

P1476

Q33401403-2AE88F55-A92B-46FF-88C9-A919CF942168

P2093

Q33401403-3A25BF40-3D68-40A2-859B-E4958C8C5836

Q33401403-5460E1C0-B062-4877-B253-C4BFC444BC3B

Q33401403-8CD0F827-1611-4316-8AF9-750F762E80DE

Q33401403-9B4266D5-F0FD-4239-8EA1-78E93C04F208

Q33401403-AE67D1B9-D835-4C31-A69F-A15C3AF16E8C

Q33401403-D65E2622-2782-4AD1-A833-627ED9AA9121

Q33401403-F39D4277-D074-4F6B-9899-90A4BC70D15A

P2860

Q33401403-00E635C7-83CB-4F2A-A2C2-EEE74B17A2B6

Q33401403-03EF6800-0C41-4402-938D-FC91E151A7EB

Q33401403-06580C49-8A9D-44C0-BDAA-3E75A23D5DF4

Q33401403-0ABDAAF0-9C7D-41E2-9B23-A0B938702095

Q33401403-0D51063F-ECD7-489D-8B1F-17300AAD9A65

Q33401403-1063C1D6-0F40-48AC-B636-F53781C3658B

Q33401403-137C00AC-E58C-4861-B5BA-34CB3F5A0EB9

Q33401403-1B49EEB3-CBC7-4C27-9223-76FE9394F687

Q33401403-1B947A60-58CE-4587-884C-880DC6F2E2C4

Q33401403-1CDBE78F-218B-4589-849A-27985228B03C

P304

Q33401403-DC2816BC-F7D3-49E2-9FAD-60EBA4A1CFC3

P31

Q33401403-4D0C690A-FFA0-4647-B06F-E2D52A7A807E

P356

Q33401403-AB1EE61A-C252-49B6-B3EE-914BAAA654C8

P407

Q33401403-B05D101D-1AF9-437C-B245-154BBAA287FE

P433

Q33401403-C5639AA6-BD21-44AC-8E64-A985EACD282D

P478

Q33401403-81523FF3-0CD3-49F4-952F-02CC639DCC6C

P50

Q33401403-2A827D99-018C-4CB3-B1B4-6BF03B507A5D

Q33401403-D739B6F5-B44B-4C1E-8F81-65A2276E59B2

P577

Q33401403-CCB0CBD1-4A41-475F-99C5-A068704B3B3E

P5875

Q33401403-81F55ACD-C051-415B-A67F-FD5A09FAFDB6

P698

Q33401403-680907F8-8914-4D39-82D3-F8FF6DC3E68F

P921

Q33401403-6E8F6EBF-75FD-4318-8421-76A608F9299F

P356

J.1365-2141.2012.09167.X

P1433

British Journal of Haematology

P1476

Guidelines on the diagnosis an ...... thrombotic microangiopathies.

@en

P2093

Betty Cheung

http://www.w3.org/2001/XMLSchema#string

Beverley J Hunt

http://www.w3.org/2001/XMLSchema#string

Marie Scully

http://www.w3.org/2001/XMLSchema#string

Peter Rose

http://www.w3.org/2001/XMLSchema#string

Ri Liesner

http://www.w3.org/2001/XMLSchema#string

Samuel J Machin

http://www.w3.org/2001/XMLSchema#string

Sylvia Benjamin

http://www.w3.org/2001/XMLSchema#string

P2860

Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura

Eculizumab in severe Shiga-toxin-associated HUS

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group

A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.

Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases.

Defibrotide in recurrent thrombotic thrombocytopenic purpura.

Von Willebrand factor--cleaving protease activity in congenital thrombotic thrombocytopenic purpura.

Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease.

P304

323-335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2141.2012.09167.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

158

http://www.w3.org/2001/XMLSchema#string

P50

British Committee for Standards in Haematology

P577

2012-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225042844

http://www.w3.org/2001/XMLSchema#string

P698

22624596

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia